CELLMABS
CELLMABS
Social Links:
Industry:
Biotechnology
Founded:
2019-06-05
Address:
Lisbon, Lisboa, Portugal
Country:
Portugal
Website Url:
http://www.cellmabs.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
3.2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Euro Google Maps GStatic Google Static Content Google Maps API Typekit Squarespace Squarespace Add To Cart
Similar Organizations
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Portugal Ventures
Portugal Ventures investment in Seed Round - CellmAbs
Bionova Capital
Bionova Capital investment in Seed Round - CellmAbs
Official Site Inspections
http://www.cellmabs.com Semrush global rank: 5.92 M Semrush visits lastest month: 1.39 K
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "CellmAbs"
CellmAbs - Crunchbase Company Profile & Funding
CellmAbs is a NOVA University of Lisbon spin-off company that was founded in 2019 with the funding of two of Portugal's top Life Science Venture Capital firms. CellmAbs is a rapidly …See details»
About Us - CellmAbs Biopharmaceuticals
CellmAbs is a spin-off company from NOVA University of Lisbon and was incorporated in 2019 with the investment of two of the largest Life Science Venture Capital firms in Portugal. CellmAbs is a fast-growing biotech company …See details»
CellmAbs Biopharmaceuticals
For the first time ever, researchers at CellmAbs have generated humanized antibodies with unprecedented specificity, and binding capability to glycan targets only expressed on cancer …See details»
CellmAbs - LinkedIn
CellmAbs | 3,558 followers on LinkedIn. A Leap Forward in Oncology | CellmAbs is focused on researching and developing novel anti-cancer treatmentsSee details»
CellmAbs Company Profile - Office Locations, Competitors ... - Craft
CellmAbs is a biotech company focused on the discovery and development of oncology products, aiming to deliver therapeutic and diagnostic solutions to treat patients with cancer. It develops …See details»
CellmAbs - Portugal Ventures
CellmAbs is a biotech company that specializes in developing novel anti-cancer treatments based on monoclonal antibodies (mAbs) targeting cancer-specific glycans. The company was …See details»
CellmAbs - Contacts, Employees, Board Members, Advisors
Organization. CellmAbs . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. Number of Board …See details»
People — CellmAbs Biopharmaceuticals
CellmAbs is a biotech company focused on discovering and developing cutting-edge oncology products, aiming to deliver the most effective and safe therapeutic and diagnostic solutions to …See details»
CellmAbs - NOVA University Innovation
CellmAbs is a Portuguese biotech company focused on the discovery and development of the next generation of immunotherapies, the best in class glyco-immuno-oncology drug candidates and personalized treatments. Formally …See details»
CellmAbs - VentureRadar
CellmAbs is focused on developing the best-in-class glyco-immuno-oncology solutions by targeting effectively and with great precision a specific subset of antigens that are only …See details»
CellmAbs SA - Drug pipelines, Patents, Clinical trials - Synapse
Explore CellmAbs SA with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:Biological products, Antibody drug ...See details»
CellmAbs - Updates, News, Events, Signals & Triggers - Crunchbase
CellmAbs provides research and development services on novel anti-cancer treatments. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log In. Log In. …See details»
CellmAbs - Products, Competitors, Financials, Employees, …
CellmAbs is a biopharmaceutical company specializing in precision oncology with a focus on developing antibody-based therapies for cancer treatment. The company's main offerings …See details»
CellmAbs | EU-Startups
Cellmabs is focused on researching and developing innovative biopharmaceuticals for the treatment of cancer. The team is comprised of renowned scientists and international experts in …See details»
CellmAbs Announces Patent Assignment and Licensing Agreement …
Jan 11, 2024 CellmAbs S.A. (“CellmAbs”), a Portuguese biotech company founded in 2019 and focused on the research and development of cancer-specific therapies, announced that it has …See details»
Press Release — CellmAbs Biopharmaceuticals
Press Release. CellmAbs Announces Patent Assignment and Licensing Agreement with BioNTech Lisbon, Portugal – 09 January 2024 – CellmAbs S.A. (“CellmAbs”), a Portuguese …See details»
CellmAbs' Cancer Immunotherapy Attacks the Sugar Coat of …
Jan 31, 2020 CellmAbs’ lead candidate is an antibody drug designed to block aberrant glycans on cancer cells. Blocking these aberrant glycans could unshackle the immune system and let it …See details»
Pipeline — CellmAbs Biopharmaceuticals
CellmAbs has been developing several therapeutic modalities targeting cancer-specific glycans using a unique mAb development platform. We develop innovative solutions to provide the …See details»
Inside the futuristic biotech startup Cellares that’s building a cure ...
3 days ago Inside the futuristic biotech startup Cellares that’s building a cure for cancer with $355 million in fundingSee details»
Science — CellmAbs Biopharmaceuticals
Most cancer cells on solid tumors are characterized by the expression of antigens such as aberrant glycans that confer increased malignancy to the cells.See details»